STORY SUMMARY

GLP-1s must now include warning for potential increased risk of vision loss, FDA announces

The FDA announced that GLP-1 weight loss drugs will now include warning labels indicating a potential increased risk of vision loss.

This is a brief summary of reporting from CBS News U.S.. Read the original for the full article and context.

Read original reporting ↗

More from CBS News U.S. · Latest headlines